...
首页> 外文期刊>Journal of biomedical materials research, Part A >Poly(DL-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices.
【24h】

Poly(DL-lactic acid) film surface modification with heparin for improving hemocompatibility of blood-contacting bioresorbable devices.

机译:用肝素对聚(DL-乳酸)薄膜进行表面改性,以改善血液接触型生物可吸收装置的血液相容性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This work describes a simple method to immobilize heparin by covalent bonding to the surface of poly(lactic acid) film with the aim of showing improved hemocompatibility. Carboxyl groups present in heparin molecules were activated by reaction with N-hydroxy-succinimide and allowed to react with free amino groups created at the surface of poly(DL-lactic acid) films by controlled aminolysis. Contact angle measurements and XPS analysis confirmed the binding. Quantification was determined by radioactivity using heparin labeled with tritium. The surface exhibited anti factor Xa activity, thus confirming the presence of bounded heparin that kept some biological activity. Finally platelets adhesion showed less platelet adhesion on heparin modified films as well as preserved morphology.
机译:这项工作描述了一种通过共价键合到聚乳酸膜表面固定肝素的简单方法,目的是提高血液相容性。肝素分子中存在的羧基通过与N-羟基琥珀酰亚胺反应而被激活,并通过受控的氨解作用与在聚(DL-乳酸)膜表面​​产生的游离氨基反应。接触角测量和XPS分析证实了这种结合。使用using标记的肝素通过放射性测定定量。该表面表现出抗因子Xa活性,因此证实了结合的肝素的存在保持了某些生物活性。最后,血小板粘附表现出较少的肝素修饰膜上的血小板粘附以及保留的形态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号